Kineta, Inc. (KA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Kineta, Inc.
Address
219 Terry Ave. N
Seattle, WA 98109
United States of America (the)
Phone
206 378 0400
Website
Sector
Healthcare
Industry
Biotechnology
Employees
11
First IPO Date
February 11, 2016
Key Executives
| Name | Title | Pay | Year Born |
| Pauline Kenny | Advisor | 349,716 | 1974 |
| Keith Baker | Chief Financial Officer | 485,746 | 1967 |
| Craig W. Philips | President & Secretary | 541,671 | 1961 |
| Gary Gentges | Executive Vice President of Corporate Development | 0 | N/A |
| Thierry Guillaudeux | Chief Scientific Officer | 0 | 1968 |
AD
Description
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
AD
